Substantial imbalance that is never eliminated with propensity score matched analyses in comparing surgery to stereotactic body radiotherapy for patients with early-stage non-small cell lung cancer

Benzer Materyaller

• Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions
  Yazar:: Takeda, Atsuya, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer
  Yazar:: Takeda, Atsuya, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy
  Yazar:: Takeda, Atsuya, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Questionnaire survey comparing surgery and stereotactic body radiotherapy for lung cancer: lessons from patients with experience of both modalities
  Yazar:: Takeda, Atsuya, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume
  Yazar:: Tsurugai, Yuichiro, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)